Aurobindo Pharma today said that different funds belonging to HDFC Trustee Company had purchased 5.01% stake in the firm.
Different funds of HDFC Trustee Company have purchased 145,93,640 equity shares amounting to 5.01% of the paid up equity share capital, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).
The purchase was carried out in open market on and the company did not provide the value of the acquisition. However, based on closing price of Aurobindo Pharma's scrips of Rs 143.70 per share on August 18 on the BSE, the stake would be worth nearly Rs 210 crore.
The different funds of HDFC Trustee Company which bought stake in Aurobindo Pharma include, HDFC arbitrage fund, HDFC balanced fund, HDFC equity fund, HDFC prudence fund, HDFC top 200 fund and HDFC mid cap opportunities.
Shares of Aurobindo Pharma today closed at Rs 137.10 on the BSE, down 4.59% from its previous close.